Effect of orthovanadate on platelet aggregation induced by platelet-activating factor

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 11, 2004, Pages 1859-1863

  Suenaga, Aya ^a   Ueki, Hiroshi ^a  

^a FUKUYAMA UNIVERSITY   (Japan)

Author keywords

Butoxamine; cAMP; cAMP dependent protein kinase; Genistein; Orthovanadate; Platelet aggregation

Indexed keywords

8 BROMO CYCLIC AMP; ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTOXAMINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GENISTEIN; ORTHOVANADIC ACID; SALBUTAMOL; THROMBOCYTE ACTIVATING FACTOR; ANTITHROMBOCYTIC AGENT; BETA 2 ADRENERGIC RECEPTOR; PROPRANOLOL; VANADIC ACID;

ANIMAL CELL; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; ENZYME ACTIVATION; ENZYME ASSAY; NONHUMAN; THROMBOCYTE AGGREGATION; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY; RABBIT; TIME;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ALBUTEROL; ANIMALS; BUTOXAMINE; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENISTEIN; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROPRANOLOL; RABBITS; RECEPTORS, ADRENERGIC, BETA-2; TIME FACTORS; VANADATES;

EID: 22044432295     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1859     Document Type: Article

References (49)

1. Cantley L. C., Jr., Josephson L., Waener R., Yanagisawa M., Lechene C., Guidotti G., J. Biol. Chem., 252, 7421-7423 (1977).
2. Swarup G., Speeg K. V., Jr., Cohen S., Garbers D. L., J. Biol. Chem., 257, 7298-7301 (1982).
3. Shisheva A., Shechter Y., Biochemistry, 31, 8059-8063 (1992).
4. Tamura S., Brown T. A., Whipple J. H., Fujita-Yamaguchi Y., Dubler R. E., Cheng K., Larner J., J. Biol. Chem., 259, 6650-6658 (1984).
5. Duckworth W. C., Solomon S. S., Liepnieks J., Hamel F. G., Hand S., Peavy D. E., Endocrinology, 122, 2285-2289 (1988).
6. Ueki H., Okuhama R., Sera M., Inoue T., Tominaga N., Morita T., Endocrinology, 131, 441-446 (1992).
7. Ueki H., Mitsugi S., Kawashima Y., Motoyashiki T., Morita T., Endocrinology, 138, 2784-2789 (1997).
8. Sera M., Tanaka K., Morita T., Ueki H., Arch. Biochem. Biophys., 279, 291-297 (1990).
9. Heyliger C. E., Tahiliani A. G., McNeil J. H., Science, 227, 1474-1476 (1985).
10. Morita T., Sakata K., Kanagawa A., Ueki H., Biol. Pharm. Bull., 17, 577-580 (1994).
11. Motoyashiki T., Morita T., Ueki H., Biol. Pharm. Bull., 19, 1412-1416 (1996).
12. Davie E. W., Fujikawa K., Annu. Rev. Biochem., 44, 799-829 (1975).
13. Siess W., Physiol. Rev., 69, 58-78 (1989).
14. Vizcaino-Salazar G., Invest. Clin., 35, 41-62 (1994).
15. Porta C., Maiolo A., Tua A., Grignani G., Haematologia, 85, 820-825 (2000).
16. Soslau G., Youngprapakorn D., Biochim. Biophys. Acta, 1355, 131-140 (1997).
17. Lages B., Weiss H. J., Thromb. Haemost., 81, 286-292 (1999).
18. Grigorian G. Y., Mirzapoyazova T. Y., Resink T. J., Danilov S. M., Tkachuk V. A., J. Mol. Cell Cardiol., 21 (Suppl. 1), 119-123 (1989).
19. Funakoshi T., Shimada H., Kojima S., Kubota Y., Morita T., Tominaga N., Ueki H., Chem. Pharm. Bull., 40, 174-176 (1992).
20. Inazu T., Taniguchi T., Yanagi S., Yamamura H., Biochem. Biophys. Res. Commun., 170, 259-263 (1990).
21. Blake R. A., Walker T. R., Watson S. P., Biochem. J., 290, 471-475 (1993).
22. Chiang T. M., Thromb. Res., 67, 345-354 (1992).
23. Akiba S., Murata T., Kitatani K., Sato T., Biol. Pharm. Bull., 23, 1293-1297 (2000).
24. Shah B. H., Rasheed H., Rahman I. H., Shariff A. H., Khan F. L., Rahman H. B., Hanif S., Saeed S. A., Exp. Mol. Med., 33, 226-233 (2001).
25. Horn F., Coutinho dos Santos P., Termignoni C., Arch. Biochem. Biophys., 384, 68-73 (2000).
26. Funakoshi T., Heimark R. L., Hendrickson L. E., McMullen B. A., Fujikawa K., Biochemistry, 26, 5572-5578 (1987).
27. Watanabe T., Satoh H., Kohara K., Takami R., Motoyashiki T., Morita T., Ueki H., Biol. Pharm. Bull., 27, 789-796 (2004).
28. Barrett A. M., Cullun V. A., Br. J. Pharmacol., 34, 43-55 (1968).
29. Hidaka H., Kobayashi R., Annu. Rev. Pharmacol. Toxicol., 32, 377-397 (1992).
30. Kerry R., Scrutton M. C., Br. J. Pharmacol., 79, 681-691 (1983).
31. Freyss-Beguin M., Griffaton G., Lechat P., Picken D., Quennedey M. C., Rouot B., Schwartz J., Br. J. Pharmacol., 78, 717-723 (1983).
32. Wasserman M. A., Lew B., J. Pharmacol. Exp. Ther., 182, 256-263 (1972).
33. Eriksson J. W., Jansson P. A., Foley K., Lithell H., J. Hypertens., 14, 1469-1475 (1996).
34. Koike K., Takayanagi I., Ichino T., Koshikawa H., Nagatomo T., Eur. J. Pharmacol., 334, 217-221 (1997).
35. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y., J. Biol. Chem., 262, 5592-5595 (1987).
36. Liu M., Simon M. I., Nature (London), 382, 83-87 (1996).
37. Zavoico G. B., Feinstein M. B., Biochem. Biophys. Res. Commun., 120, 579-585 (1984).
38. Ryningen A., Jensen B. O., Holmsen H., Biochim. Biophys. Acta, 1394, 234-248 (1998).
39. Combest W. L., Johnson R. A., Arch. Biochem. Biophys., 225, 916-927 (1983).
40. Tan C. M., Macdonald C. J., Chorazyczewski J., Burry A. F., Feldman R. D., Clin. Pharmacol. Ther., 66, 275-281 (1999).
41. Tan C. M., Kelvin D. J., Lichfield D. W., Ferguson S. S. G., Feldman R. D., Biochemistry, 40, 1702-1709 (2001).
42. Vassbotn F. S., Havnen O. K., Heldin C. H., Holmsen H., J. Biol. Chem., 269, 13874-13879 (1994).
43. Pyne N. J., Pyne S., Cell Signal., 10, 363-369 (1998).
44. Davidai G., Lee A., Schvartz I., Hazum E., Am. J. Physiol., 263 (2 Pt 1), E205-209 (1992).
45. Okada T., Sakuma I., Fukui Y., Hazeki O., Ui M., J. Biol. Chem., 269, 3563-3567 (1994).
46. Pang L., Sawada T., Decker S. J., Saltiel A. R., J. Biol. Chem., 270, 13585-13588 (1995).
47. Lauener R. W., Stevens C. M., Sayed M. R., Salari H., Duronio V., Biochim. Biophys. Acta, 1452, 197-208 (1999).
48. Lee C. M., Onesim D., Reddy C. D., Dhanasekaran N., Reddy E. P., Proc. Natl. Acad. Sci. U.S.A., 99, 14189-14194 (2002).
49. Papkoff J., Chen R. H., Blenis J., Forsman J., Mol. Cell Biol., 14, 463-472 (1994).